↓ Skip to main content

Dove Medical Press

Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, October 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
1 X user
facebook
1 Facebook page
googleplus
1 Google+ user

Citations

dimensions_citation
146 Dimensions

Readers on

mendeley
378 Mendeley
Title
Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, October 2012
DOI 10.2147/dmso.s28340
Pubmed ID
Authors

Christoph Rosak, Gabriele Mertes

Abstract

The alpha-glucosidase inhibitor acarbose has been used for more than 20 years in the management of hyperglycemia. Owing to its unique mode of action in the gastrointestinal tract, its properties are very different from other antidiabetic medications. Patients on long-term treatment to control a chronic disease are not only interested in good treatment efficacy, but are also even more interested in the safety and side effects of their medications. Significant aspects of acarbose predominantly regarding safety and tolerability in the management of type 2 diabetes and prediabetes are reviewed. It is concluded that acarbose is a convenient long-term treatment option, with benefits for both type 2 diabetics and patients in a prediabetic state.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 378 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
Puerto Rico 1 <1%
Unknown 376 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 74 20%
Student > Master 36 10%
Student > Ph. D. Student 33 9%
Other 13 3%
Researcher 13 3%
Other 51 13%
Unknown 158 42%
Readers by discipline Count As %
Medicine and Dentistry 47 12%
Pharmacology, Toxicology and Pharmaceutical Science 43 11%
Biochemistry, Genetics and Molecular Biology 33 9%
Agricultural and Biological Sciences 32 8%
Chemistry 31 8%
Other 25 7%
Unknown 167 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2017.
All research outputs
#16,046,765
of 25,373,627 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#505
of 1,180 outputs
Outputs of similar age
#116,486
of 190,982 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#1
of 7 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,180 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,982 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them